Clinical trials
Phase 3 Endometrial Neoplasms trials in Sweden
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Completed | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| AstraZeneca | 1 |
| BioNTech SE | 1 |
| R-Pharm | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 9 |
| Sarcoma | 2 |
| Sarcoma, Endometrial Stromal | 2 |
| Fibrosarcoma | 1 |
| Hemangiosarcoma | 1 |
| Histiocytoma, Malignant Fibrous | 1 |
| Kidney Neoplasms | 1 |
| Leiomyosarcoma | 1 |
| Liposarcoma | 1 |
| Neoplasm Metastasis | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.